The bile acid TUDCA and neurodegenerative disorders: An overview

被引:68
|
作者
Zangerolamo, Lucas [1 ]
Vettorazzi, Jean F. [2 ]
Rosa, Lucas R. O. [1 ]
Carneiro, Everardo M. [1 ]
Barbosa, Helena C. L. [1 ]
机构
[1] Univ Estadual Campinas, UNICAMP, Dept Struct & Funct Biol, Obes & Comorbid Res Ctr, Campinas, SP, Brazil
[2] UNIVEL, Educ Union Cascavel, Cascavel, Parana, Brazil
基金
巴西圣保罗研究基金会;
关键词
Bile acids; Neurodegeneration; Neuroprotection; Alzheimer's disease; Parkinson's disease; Huntington's disease;
D O I
10.1016/j.lfs.2021.119252
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Bear bile has been used in Traditional Chinese Medicine for thousands of years due to its therapeutic potential and clinical applications. The tauroursodeoxycholic acid (TUDCA), one of the acids found in bear bile, is a hydrophilic bile acid and naturally produced in the liver by conjugation of taurine to ursodeoxycholic acid (UDCA). Several studies have shown that TUDCA has neuroprotective action in several models of neurodegenerative disorders (ND), including Alzheimer's disease, Parkinson's disease, and Huntington's disease, based on its potent ability to inhibit apoptosis, attenuate oxidative stress, and reduce endoplasmic reticulum stress in different experimental models of these illnesses. Our research extends the knowledge of the bile acid TUDCA actions in ND and the mechanisms and pathways involved in its cytoprotective effects on the brain, providing a novel perspective and opportunities for treatment of these diseases.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Stroke and neurodegenerative disorders. 4. Neurodegenerative disorders
    Bryant, PR
    Geis, CC
    Moroz, A
    O'Neill, BJ
    Bogey, RA
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2004, 85 (03): : S21 - S33
  • [42] Ferulic acid ethyl ester as a potential therapy in neurodegenerative disorders
    Sultana, Rukhsana
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (05): : 748 - 752
  • [43] Sulfopropanoic acid derivatives for treating neurodegenerative disorders: a patent spotlight
    Al-Horani, Rami A.
    PHARMACEUTICAL PATENT ANALYST, 2024,
  • [44] Bile acid TUDCA improves insulin clearance by increasing the expression of insulin-degrading enzyme in the liver of obese mice
    Jean Franciesco Vettorazzi
    Mirian Ayumi Kurauti
    Gabriela Moreira Soares
    Patricia Cristine Borck
    Sandra Mara Ferreira
    Renato Chaves Souto Branco
    Luciana de Souza Lima Michelone
    Antonio Carlos Boschero
    Jose Maria Costa Junior
    Everardo Magalhães Carneiro
    Scientific Reports, 7
  • [45] Structure-function analysis of the tertiary bile acid TUDCA for the resolution of endoplasmic reticulum stress in intestinal epithelial cells
    Berger, Emanuel
    Haller, Dirk
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 409 (04) : 610 - 615
  • [46] CHALLENGES IN ACID PEPTIC DISORDERS - A SYMPOSIUM OVERVIEW
    CLEARFIELD, HR
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1991, 5 : 1 - 4
  • [47] Potential of Capric Acid in Neurological Disorders: An Overview
    Shekhar, Nikhila
    Tyagi, Sakshi
    Rani, Sweta
    Thakur, Ajit Kumar
    NEUROCHEMICAL RESEARCH, 2023, 48 (03) : 697 - 712
  • [48] Potential of Capric Acid in Neurological Disorders: An Overview
    Nikhila Shekhar
    Sakshi Tyagi
    Sweta Rani
    Ajit Kumar Thakur
    Neurochemical Research, 2023, 48 : 697 - 712
  • [49] TAUROURSODEOXYCHOLIC ACID (TUDCA) APPEARS MORE EFFECTIVE THAN UDCA AT DISPLACING HYDROPHOBIC BILE-ACIDS FROM THE BILE-ACID POOL OF PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS (PBC)
    SETCHELL, KDR
    RODRIGUES, C
    PODDA, M
    CROSIGNANI, A
    HEPATOLOGY, 1994, 20 (04) : A150 - A150
  • [50] FXR, a therapeutic target for bile acid and lipid disorders
    Westin, S
    Heyman, RA
    Martin, R
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (08) : 719 - 727